Abingdon Heath plc’s CEO, Chris Yates, firmly believes that lateral flow tests (LFTs) are poised to revolutionise environmental testing. Click to read more.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Abingdon Health s chief executive officer Chris Yates and chairman Dr Chris Hand, pictured in 2019. A YORK-based diagnostics company whose products include Covid-19 antibody tests has raised £22m in a flotation on the AIM market of the London Stock Exchange today. The flotation values Abingdon Health which secured an order from the government for one million of its rapid Covid-19 antibody tests in October at around £92m. Chief executive officer Chris Yates said the move was an important milestone . Abingdon is a lateral flow diagnostics company providing contract service solutions to clients globally in healthcare and other industries. Its services include product development, regulatory support, technology transfer and commercial manufacturing.